Activation of procarcinogens by human cytochrome P450 enzymes

This publication has 90 references indexed in Scilit:

• Aflatoxin B₁epoxidation catalysed by partially purified human liver lipoxygenase
  Xenobiotica, 1997
• Specificity of cDNA-expressed human and rodent cytochrome P450s in the oxidative metabolism of the potent carcinogen 7,12-dimethylbenz[a]anthracene
  Molecular Carcinogenesis, 1996
• Salmonella strains and mammalian cells genetically engineered for expression of sulfotransferases
  Toxicology Letters, 1995
• High promutagen activating capacity of yeast microsomes containing human cytochrome P-450 1A and human NADPH-cytochrome P-450 reductase
  Carcinogenesis: Integrative Cancer Research, 1994
• Restriction fragment length polymorphism of the human CYP 2E1 (cytochrome P450IIE1) gene and susceptibility to lung cancer
  Pharmacogenetics, 1994
• 1462V mutation in the human CYP1A1 gene
  Pharmacogenetics, 1994
• Roles of different forms of cytochrome P450 in the activation of the promutagen 6-aminochrysene to genotoxic metabolites in human liver microsomes
  Carcinogenesis: Integrative Cancer Research, 1993
• The P450 Superfamily: Update on New Sequences, Gene Mapping, Accession Numbers, Early Trivial Names of Enzymes, and Nomenclature
  DNA and Cell Biology, 1993
• Human Cytochrome P450IIE1 Gene. DraI Polymorphism and Susceptibility to Cancer.
  The Tohoku Journal of Experimental Medicine, 1992
• Hypotensive response to debrisoquine and hydroxylation phenotype
  Life Sciences, 1978